title: Successful treatment of angioimmunoblastic T-cell lymphoma with the retinoid X receptor agonist, bexarotene.
authors.forename: Donald E
authors.initials: DE
authors.lastname: Tsai
authors.forename: Elise
authors.initials: E
authors.lastname: Chong
authors.forename: Adam
authors.initials: A
authors.lastname: Bagg
authors.forename: Sharon
authors.initials: S
authors.lastname: Arnoldi
authors.forename: Jakub
authors.initials: J
authors.lastname: Svoboda
authors.forename: Sunita
authors.initials: S
authors.lastname: Nasta
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Schuster
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077610:Bexarotene; D005260:Female; D006801:Humans; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008875:Middle Aged; D047488:Retinoid X Receptors / Q000819:agonists*; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047488:Retinoid X Receptors; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene